|Articles|April 1, 2020
- BioPharm International-04-01-2020
- Volume 33
- Issue 4
BioPharm International, April 2020 Issue (PDF)
Click the title above to open the BioPharm International April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Bioreactors Redefine Upstream Productivityover 5 years ago
Critical Knowledge for Preparing Auditsover 5 years ago
Can Vaccine Development Be Safely Accelerated?over 5 years ago
What’s New in Downstream Technologiesover 5 years ago
Benchtop Centrifugesover 5 years ago
Chromatography Columnsover 5 years ago
Ensuring Smooth Tech Transfer of Bioprocess Operationsover 5 years ago
Biosimilars Tackle Interchangeability Standardsover 5 years ago
Contamination Control for Cell TherapyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
